CytoCore, Inc. (CCI), formerly Molecular Diagnostics, Inc., is a biotechnology company involved in designing, developing and commercializing cost-effective screening systems for the early detection of cancer. The major product developed by the company is CytoCore Solutions System, a simple and cost-effective method to screen women for endometrial cancer. It is comprised of four distinct components namely the SoftPAP cervical cell collector, the AIPS microscope platform, drug delivery system for treating cervical lesions, and a protein-based biochemical cocktails and slide-based tests. In addition, CCI also licensed to sell the PadKit, asample collection device for cytological applications by Cell Solutions LLC. The company is headquartered in Illinois, the US.